The pharmaceutical industry is one of the most profitable sectors globally. It is dedicated to discovering, developing, and manufacturing drugs for the diagnosis, treatment, and prevention of various diseases. This industry is constantly growing, driven by an aging population, new medical breakthroughs, and an increase in chronic diseases.Investors, therefore, have a huge opportunity to make money in this sector. Two of the most renowned brands in the pharmaceutical industry are Johnson & Johnson and Pfizer.
Johnson & Johnson: A Brief History
Johnson & Johnson is an American multinational corporation established in 1886. It has become a leading company in the pharmaceutical, consumer health, and medical devices sectors. Johnson & Johnson offers a diverse range of products, such as pharmaceuticals, baby care, beauty care, and medical devices. Its pharmaceutical division, Janssen Pharmaceutica, is responsible for developing many popular drugs, such as Invokana, Imbruvica, and Remicade®.
Pfizer: A Brief History
Pfizer was founded in 1849 by two German-American cousins, Charles Pfizer and Charles Erhart. It has become a leading company in the development, production, and sale of pharmaceuticals, vaccines, and consumer health products. Some of Pfizer’s most popular drugs include Lipitor, Viagra, and Lyrica. Pfizer has also made history with the development of the first COVID-19 vaccine in partnership with BioNTech.
Why Invest in Johnson & Johnson and Pfizer?
Investing in Johnson & Johnson and Pfizer presents numerous opportunities for investors. Both companies have a long history of success and continue to innovate in the pharmaceutical industry. Additionally, they have a diverse range of products that are highly sought after in the global market. For instance, Johnson & Johnson’s medical devices and consumer health divisions continue to drive up the company’s revenues.Furthermore, their stocks have remained relatively stable despite economic downturns, providing a safe investment for those looking for a stable return. Both companies also offer attractive dividend yields, making them a lucrative option for long-term investors. Pfizer’s dividend yield in 2021 is around 4%, while Johnson & Johnson’s is around 2%.
The pharmaceutical industry offers investors a huge opportunity to make money. Renowned brands such as Johnson & Johnson and Pfizer are particularly attractive due to their history of success, diverse product range and stability. Therefore, investing in these companies is an excellent way to diversify your portfolio and generate long-term returns.